ArticleDiabetes, obesity, and cardiometabolic CARE
Advancing Type 2 Diabetes Care: The Role of Continuous Glucose Monitoring in Noninsulin-Treated Patients.
Article in Diabetes, obesity, and cardiometabolic CARE. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Continuous glucose monitoring (CGM) is standard of care as part of diabetes management for people with type 1 or type 2 diabetes using insulin therapy. Recently, the American Diabetes Association recommended CGM use be considered in adults with type 2 diabetes using noninsulin medications for managing blood glucose levels. Despite this recommendation, many people using noninsulin therapies for type 2 diabetes encounter restrictions on access to CGM. We have reviewed the available studies exploring the utility of CGM in this patient population, with a focus on glycemic management and health care resource utilization. Numerous studies focusing on this patient group, including systematic reviews and meta-analyses, randomized controlled trials, other prospective studies, and retrospective analyses, have consistently found that use of CGM is associated with improvements in HbA
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.